Related Experiment Video
Updated: Jul 12, 2026

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
C1 inhibitor-mediated protection from sepsis
Dongxu Liu1, Fengxin Lu, Gangjian Qin
1CBR Institute for Biomedical Research, Harvard Medical School, Boston, MA 02115, USA. dxliu@hubu.edu.cn
C1 inhibitor (C1INH) enhances the immune system's ability to clear bacteria, improving survival in sepsis models. This protein boosts phagocyte activity, offering a potential therapeutic strategy for sepsis and peritonitis.
Area of Science:
- Immunology
- Microbiology
- Biochemistry
Background:
- Sepsis, a life-threatening condition, involves a dysregulated host response to infection.
- Gram-negative bacterial lipopolysaccharide (LPS) is a key trigger of endotoxin shock.
- C1 inhibitor (C1INH) is a serine protease inhibitor with known roles in inflammation and complement regulation.
Purpose of the Study:
- To investigate the protective mechanisms of C1 inhibitor against Gram-negative bacterial sepsis.
- To determine if C1INH's protective effects extend beyond complement and contact system inhibition.
- To evaluate C1INH as a potential therapeutic agent for sepsis.
Main Methods:
- Utilized the cecal ligation and puncture (CLP) mouse model of sepsis.
- Administered C1 inhibitor (C1INH) and its inactive form (iC1INH) to mice.
- Assessed bacterial load, survival rates, and phagocyte activity (neutrophils and macrophages) in vitro and in vivo.
- Compared outcomes in C1INH-deficient mice versus wild-type littermates.
Main Results:
- C1INH treatment improved survival in CLP-induced sepsis.
- Both active C1INH and inactive iC1INH reduced bacterial load and enhanced bacterial killing by phagocytes.
- C1INH enhanced the uptake and bactericidal capacity of neutrophils and macrophages.
- C1INH-deficient mice exhibited higher mortality, which was reversed by C1INH administration.
Conclusions:
- C1INH confers protection against Gram-negative bacterial sepsis through mechanisms independent of complement and contact system inhibition.
- C1INH enhances innate immune cell function, particularly phagocytosis and bacterial killing.
- C1INH represents a promising therapeutic candidate for sepsis and peritonitis.
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Complement System
Hypersensitivity Reactions: Cytolytic Reactions
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Inhibitors of Gram-positive Cell Wall Synthesis

